Somatic hypermutation in normal and transformed human B cells - PubMed (original) (raw)
Review
Somatic hypermutation in normal and transformed human B cells
U Klein et al. Immunol Rev. 1998 Apr.
Abstract
In the human, most IgM+IgD+ as well as CD5+ peripheral blood B cells express unmutated V genes and thus can be assigned to a pre-germinal centre (GC) stage of development. The memory B-cell compartment generated in the GC reaction and characterized by cells bearing somatically mutated V-region genes consists not only of class-switched cells, but also of IgM-only B cells and perhaps a subset of IgM+IgD+B cells expressing the CD27 antigen. Comparison of the rearranged V-region genes of human B-cell lymphomas with those of the normal B-cell subsets allows the identification of the progenitor cells of these tumours in terms of their stage of maturation. On this basis, most B-cell non-Hodgkin lymphomas, and in addition Hodgkin and Reed-Sternberg (HRS) cells in Hodgkin's disease (HD), are derived from B cells at a GC or post-GC stage of development. The mutation pattern indicates that the precursors of the tumour clones have been stringently selected for expression of a functional antigen receptor with one notable exception: HRS cells in classical (but not lymphocyte-predominant) HD appear to be derived from "crippled" GC B cells. Sequence analysis of rearranged V genes amplified from single tonsillar GC B cells revealed that the somatic hypermutation process introduces deletions and/or insertions into V-region genes more frequently than indicated by previous investigations. Presumably, this feature of the hypermutation mechanism is often responsible for the generation of heavy chain disease, and also several types of chromosomal translocations of oncogenes into immunoglobulin loci in human B-cell lymphomas.
Similar articles
- Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A, Hansmann ML, Strickler JG, Dummer R, Burg G, Rajewsky K, Küppers R. Bräuninger A, et al. N Engl J Med. 1999 Apr 22;340(16):1239-47. doi: 10.1056/NEJM199904223401604. N Engl J Med. 1999. PMID: 10210707 - Somatic hypermutation and B-cell malignancies.
Spencer JO, Dunn-Walters DK. Spencer JO, et al. J Pathol. 1999 Jan;187(2):158-63. doi: 10.1002/(SICI)1096-9896(199901)187:2<158::AID-PATH226>3.0.CO;2-6. J Pathol. 1999. PMID: 10365090 Review.
Cited by
- IgIDivA: immunoglobulin intraclonal diversification analysis.
Zaragoza-Infante L, Junet V, Pechlivanis N, Fragkouli SC, Amprachamian S, Koletsa T, Chatzidimitriou A, Papaioannou M, Stamatopoulos K, Agathangelidis A, Psomopoulos F. Zaragoza-Infante L, et al. Brief Bioinform. 2022 Sep 20;23(5):bbac349. doi: 10.1093/bib/bbac349. Brief Bioinform. 2022. PMID: 36044248 Free PMC article. - B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphoma.
Bashashati A, Johnson NA, Khodabakhshi AH, Whiteside MD, Zare H, Scott DW, Lo K, Gottardo R, Brinkman FS, Connors JM, Slack GW, Gascoyne RD, Weng AP, Brinkman RR. Bashashati A, et al. Am J Clin Pathol. 2012 May;137(5):805-14. doi: 10.1309/AJCPGR8BG4JDVOWR. Am J Clin Pathol. 2012. PMID: 22523221 Free PMC article. - Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.
Montesinos-Rongen M, Küppers R, Schlüter D, Spieker T, Van Roost D, Schaller C, Reifenberger G, Wiestler OD, Deckert-Schlüter M. Montesinos-Rongen M, et al. Am J Pathol. 1999 Dec;155(6):2077-86. doi: 10.1016/S0002-9440(10)65526-5. Am J Pathol. 1999. PMID: 10595937 Free PMC article. - The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population.
Kuze T, Nakamura N, Hashimoto Y, Sasaki Y, Abe M. Kuze T, et al. Jpn J Cancer Res. 2000 Dec;91(12):1233-40. doi: 10.1111/j.1349-7006.2000.tb00909.x. Jpn J Cancer Res. 2000. PMID: 11123421 Free PMC article. - Targeting B Cells and Plasma Cells in Autoimmune Diseases.
Hofmann K, Clauder AK, Manz RA. Hofmann K, et al. Front Immunol. 2018 Apr 23;9:835. doi: 10.3389/fimmu.2018.00835. eCollection 2018. Front Immunol. 2018. PMID: 29740441 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous